当前位置:首页 - 行情中心 - 冠昊生物(300238) - 财务分析 - 现金流量表

冠昊生物

(300238)

  

流通市值:31.68亿  总市值:32.83亿
流通股本:2.65亿   总股本:2.75亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金187,227,004.4101,005,829.08444,379,920.39327,735,041.46
  收到的税费返还39,644.4339,644.43--
  收到其他与经营活动有关的现金4,798,457.523,109,188.6611,750,433.29,845,710.89
  经营活动现金流入的平衡项目00-0
  经营活动现金流入小计192,065,106.35104,154,662.17456,130,353.59337,580,752.35
  购买商品、接受劳务支付的现金29,652,338.6714,873,172.4378,336,830.752,078,873.14
  支付给职工以及为职工支付的现金58,633,865.935,699,094.72104,379,620.0384,693,045.12
  支付的各项税费45,663,534.3533,573,913.8544,734,229.6333,297,221.85
  支付其他与经营活动有关的现金64,886,471.3133,832,621.31157,205,877.47114,875,772.07
  经营活动现金流出的平衡项目00-0
  经营活动现金流出小计198,836,210.23117,978,802.31384,656,557.83284,944,912.18
  经营活动产生的现金流量净额平衡项目00-0
  经营活动产生的现金流量净额-6,771,103.88-13,824,140.1471,473,795.7652,635,840.17
二、投资活动产生的现金流量:
  收回投资收到的现金1,500,0001,500,0003,142,712.17-
  取得投资收益收到的现金38,542.1538,542.15--
  处置固定资产、无形资产和其他长期资产收回的现金净额41,58041,12034,979.1727,914.35
  投资活动现金流入的平衡项目00-0
  投资活动现金流入小计1,580,122.151,579,662.153,177,691.3427,914.35
  购建固定资产、无形资产和其他长期资产支付的现金16,724,377.9811,898,993.6938,170,095.1529,590,534.75
  投资支付的现金--300,000-
  取得子公司及其他营业单位支付的现金--898,382.18300,000
  支付其他与投资活动有关的现金---898,382.18
  投资活动现金流出的平衡项目00-0
  投资活动现金流出小计16,724,377.9811,898,993.6939,368,477.3330,788,916.93
  投资活动产生的现金流量净额平衡项目00-0
  投资活动产生的现金流量净额-15,144,255.83-10,319,331.54-36,190,785.99-30,761,002.58
三、筹资活动产生的现金流量:
  吸收投资收到的现金--6,101,3006,101,300
  其中:子公司吸收少数股东投资收到的现金---6,101,300
  取得借款收到的现金13,219,958.7711,269,958.7745,013,50035,950,000
  筹资活动现金流入平衡项目00-0
  筹资活动现金流入小计13,219,958.7711,269,958.7751,114,80042,051,300
  偿还债务支付的现金2,382,449.61,591,417.320,010,00020,000,000
  分配股利、利润或偿付利息支付的现金1,868,496.46913,173.143,669,240.932,815,202.78
  支付其他与筹资活动有关的现金1,537,273.89761,199.556,417,169.514,056,317.98
  筹资活动现金流出平衡项目00-0
  筹资活动现金流出小计5,788,219.953,265,789.9930,096,410.4426,871,520.76
  筹资活动产生的现金流量净额平衡项目00-0
  筹资活动产生的现金流量净额7,431,738.828,004,168.7821,018,389.5615,179,779.24
四、汇率变动对现金及现金等价物的影响-359,596.12-241,730.26-182,486.94-103,782.15
  现金及现金等价物净增加额平衡项目00-0
五、现金及现金等价物净增加额-14,843,217.01-16,381,033.1656,118,912.3936,950,834.68
  加:期初现金及现金等价物余额160,602,712.5160,602,712.5104,483,800.11104,483,800.11
  期末现金及现金等价物余额平衡项目00-0
  期末现金及现金等价物余额145,759,495.49144,221,679.34160,602,712.5141,434,634.79
补充资料:
  净利润7,653,728.99-14,787,270.04-
  资产减值准备1,504,956.25-1,901,987.23-
  固定资产和投资性房地产折旧6,187,222.18-12,466,350.34-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧6,187,222.18---
  无形资产摊销3,893,402.37-8,413,414.1-
  长期待摊费用摊销382,528.61-954,754.68-
  处置固定资产、无形资产和其他长期资产的损失-88,775.14-5,119.4-
  固定资产报废损失4,191.32-76,038.05-
  财务费用1,666,673.25-4,035,969.72-
  投资损失153,040.41--1,894,614.62-
  递延所得税-53,756.09--593,785.1-
  其中:递延所得税资产减少-1,866,824.76-761,436.24-
    递延所得税负债增加1,813,068.67--1,355,221.34-
  存货的减少11,375,510.77--625,486.88-
  经营性应收项目的减少-15,929,764.77-17,760,909.56-
  经营性应付项目的增加-24,726,394.88-8,129,854.08-
  现金的期末余额145,759,495.49-160,602,712.5-
  减:现金的期初余额160,602,712.5-104,483,800.11-
  现金及现金等价物的净增加额-14,843,217.01-56,118,912.39-
公告日期2026-08-292026-04-292026-03-262025-10-29
审计意见(境内)标准无保留意见
TOP↑